<?xml version="1.0" encoding="UTF-8"?>
<ref id="B168-pharmaceuticals-12-00147">
 <label>168.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Luo</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Liang</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Zhu</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Sun</surname>
    <given-names>N.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Phospholipid scramblase 1 interacts with influenza A virus NP, impairing its nuclear import and thereby suppressing virus replication</article-title>
  <source>PLoS Pathog.</source>
  <year>2018</year>
  <volume>14</volume>
  <elocation-id>e1006851</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.ppat.1006851</pub-id>
  <?supplied-pmid 29352288?>
  <pub-id pub-id-type="pmid">29352288</pub-id>
 </element-citation>
</ref>
